Skip to main content
SpringerLink
Log in

Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients: a prospective longitudinal study

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Although there is a consensus that orofacial and limbtruncal subtypes of tardive dyskinesia (TD) exist and may represent distinct pathophysiologic entities, few studies have examined the incidence of and risk factors associated with the development of these TD subtypes. Two hundred and sixty-six middle-aged and elderly outpatients with a median duration of 21 days of total lifetime neuroleptic exposure at study entry were evaluated at 1- to 3-month intervals. Using “mild” dyskinesia in any part of the body for diagnosis of TD, the cumulative incidence of orofacial TD was 38.5 and 65.7% after 1 and 2 years, respectively, whereas that of limbtruncal TD was 18.6 and 32.6% after 1 and 2 years. Preclinical dyskinesia was predictive of both orofacial and limbtruncal TD. History of alcohol abuse or dependence was a significant predictor of orofacial TD only whereas tremor was a significant predictor of limbtruncal TD only. Findings support suggestions that orofacial and limbtruncal TD may represent specific subsyndromes with different risk factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, Third Edition, Revised. American Psychiatric Press, Washington, DC

    Google Scholar 

  • American Psychiatric Association (1994) Diagnostic criteria from DSM-IV. American Psychiatric Association, Washington, DC

    Google Scholar 

  • Arendt T, Bigl V, Arendt A, Tennstedt A (1983) Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease. Acta Neuropathol 61: 101–108

    Google Scholar 

  • Baldessarini RJ, Cole JO, Davis JM, Gardos G, Preskorn SH, Tarsy D (1980) Tardive dyskinesia: a task force report of the American Psychiatric Association. American Psychiatric Association, Washington, DC

    Google Scholar 

  • Brown KW, White T (1991) The association among negativesymp toms, movement disorders, and frontal lobe psycholo gical deficits in schizophrenic patients. Biol Psychiatry 30: 1182–1190

    Google Scholar 

  • Brown KW, White T (1992) The influence of topography on the cognitive and psychopathological effects of tardive dyskinesia. Am J Psychiatry 49: 1385–1389

    Google Scholar 

  • Butters N, Wolfe J, Martone M, Granholm E, Cermak LS (1985) Memory disorders associated with Huntington's disease: verbal recall, verbal recognition and procedural memory. Neuropsychologia 23: 29–743

    Google Scholar 

  • Caligiuri MP, Lohr JB (1993) Worsening of postural tremor in patients with levodopa-induced dyskinesia: a quantitative analysis. Clin Neuropharmacol 16: 244–250

    Google Scholar 

  • Caligiuri MP, Lohr JB, Bracha HS, Jeste DV (1991a) Clinical and instrumental assessment of neuroleptic-induced parkinson ism in patients with tardive dyskinesia. Biol Psychiatry 29: 139–148

    Google Scholar 

  • Caligiuri MP, Lohr JB, Jeste DV (1991b) Instrumental evidence that age increases motor instability in neuroleptic-treated patients. J Gerontol 46: B197-B200

    Google Scholar 

  • Casey DE (1988) Affective disorders and tardive dyskinesia. L'Encephale 14: 221–226

    Google Scholar 

  • Casey De, Denney D (1977) Pharmacological characterization of tradive dyskinesia. Psychopharmacology 54: 1–9

    Google Scholar 

  • cassey DE, Gerlach J (1986) Tardive dyskinesia: what is the longterm outcome? In: Casey DE, Gardos G (eds) Tardive dyskinesia and neuroleptics: from dogma to Reason. American Psychiatric Press, Washington, DC pp 75–97

    Google Scholar 

  • Collett D (1994) Modelling survival data in medical research. Chapman and Hall, London

    Google Scholar 

  • Cancato J, Feinstein AR, Holford TR (1993) The risk of determining risk with multivariable models. Ann Int Med 118: 201–210

    Google Scholar 

  • Cox DR (1972) Regression models and life tables. J R Statist Soc Ser B 34: 187–220

    Google Scholar 

  • Crane GE (1972) Pseudoparkinsonism and tardive dyskinesia. Arch Neurol 27: 426–430

    Google Scholar 

  • Crane GE (1974) Factors predisposing to drug-induced neurologic medication. In: Forrest IS, Carr CJ, Usdin E (eds) The phenothiazines and structurally related drugs. Raven Press, New York, pp 269–279

    Google Scholar 

  • Cutler SJ, Ederer F (1958) Maximum utilization of the life table method in analyzing survival. J Chron Dis 8: 669–712

    Google Scholar 

  • Dixon, L, Weiden PJ, Haas G, Sweeney J, Francese AJ (1992) Increased tardive dyskinesia in alcohol-abusing schizophrenic patients. Comp Psychiatry 33: 121–122

    Google Scholar 

  • Dixon WJ (chief ed.) (1992) BMPD statistical software manual (vol. 1 and vol. 2). University of California Press, Berkeley

    Google Scholar 

  • Duke PJ, Pantelis C, Bames TR (1994) South Westminster schizophrenia survey: alcohol use and its relationship to symptoms, tardive dyskinesia and illness on set. Br J Psychiatry 164: 630–636

    Google Scholar 

  • Folstein MF, Folstein SE, McHugh PR (1975) Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198

    Google Scholar 

  • Ganzini L, Casey DE, Hoffman WF, Heintz RT (1991a) Tardive dyskinesia in neuroleptic-treated diabetics. 30th Annual Meeting of the American College of Neuropsychopharmacology: Abstracts of Panels and Posters, p 162

  • Ganzini L, Heintz RT, Hoffman WF, Casey DE (1991b) The prevalence of tardive dyskinesia in neuroleptic-treated diabetics: a controlled study. Arch Gen Psychiatry 48: 259–263

    Google Scholar 

  • Gardos G, Cole JO, Haskell D, Marby D, Paine SS, Moore P (1988) The natural history of tradive dyskinesia. J Clin Psychopharmacol 8: 31S-37S

    Google Scholar 

  • Glazer WM, Morgenstern H (1988) Predictors of occurrence, Severity, and course and tardive dyskinesia in an outpatient population. J Clin Psychopharmacol 8: 10S-16S

    Google Scholar 

  • Grant I (1987) Life events do not predict symptoms predict symptoms. J Behav Med 10: 231–240

    Google Scholar 

  • Gureje O (1988) Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables. J Neurol Neurosurg Psychiatry 51: 1525–1530

    Google Scholar 

  • Gureje O (1989) The significance of subtyping tardive dyskinesia: a study of prevalence and associated factors. Psychol Med 19: 21–128

    Google Scholar 

  • Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6: 278–296

    Google Scholar 

  • Hansen TE, Casey DE, Vollmer WM (1986) Is there an epidemic of tardive dyskinesai? In: Casey DE, Gardos G (eds) Tardive dyskinesia and neuroleptics: from dogma to reason. American Psychiatric Press, Washington, DC pp 1–14

    Google Scholar 

  • Jeste DV, Caligiuri MP (1993) Tardive dyslinesia. Schizophr Bull 19: 303–315

    Google Scholar 

  • Jeste DV, Wyatt, RJ (1982) Understanding and treating tardive dyskinesia. Guilford Press, New York

    Google Scholar 

  • Jeste DV, Lohr JB, Kaufmann CA, Wyatt RJ (1986) Pathophysiology of tardive dyskinesia: evaluation of supersensitivity theory and alternative hypotheses. In: Casey D, Gardos G (eds) Tardive Dyskinesia: from dogma to reason. American Psychiatric Press, Washington, DC, pp 15–32

    Google Scholar 

  • Jeste DV, Caligiuri MP, Paulsen JS, Heaton RK, Lacro JP, Harris MJ, Bailey A, Fell RL, McAdams LA (1995) Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 patients. Arch Gen Psychiatry 52:756–765

    Google Scholar 

  • Kane JM, Smith JM (1982) Tradive dyskinesia: prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry 39:473–481

    Google Scholar 

  • Kane JM, Woerner M, Lieberman J (1988) Tardive dyskinesia: prevalence, incidence, and risk factors. J Clin Psychopharmacol 8 [4]:52S-56S

    Google Scholar 

  • Kane JM, Jeste DV, Barmes TRE, Casey DE, Cole JO, Davis JM, Gualtieri CT, Schooler NR, Sprague RL, Wettstein RM (1992) Tardive dyskinesia: a task force report of the American Psychiatric Association. American Psychiatric Association, Washington DC

    Google Scholar 

  • Khot V, Wyatt RJ (1991) Not all that moves is tardive dyskinesia. Am J Psychiatry 148:661–666

    Google Scholar 

  • Kidger T, Bames TRE, Trauer T, Taylor PJ (1980) Sub-syndromes of tradive dyskinesia. Psychol Med 10:513

    Google Scholar 

  • Klawans H, Rubovits R (1974) Effect of cholinergic and anticholinergic agents on tardive dyskinesia. J Neurol Neurosurg Psychiatry 27:941–945

    Google Scholar 

  • Koller WC, Vetere-Overfield B, Barter R (1989) Tremors in early Parkinson's disease. Clin Neuropharmacol 12:293–297

    Google Scholar 

  • Lieberman J, Lesser M, Johns C, Pollack S, Saltz B, Kane J (1988a) Pharmacologic studies of tardive dyskinesia. J Clin Psychopharmacol 8:57S-63S

    Google Scholar 

  • Lieberman J, Pollack S, Lesser M, Kane J (1988b) Pharmacologic characterization of tardive dyskinesia. J Clin Psychopharmacol 8:254–257

    Google Scholar 

  • Lohr J, Wisniewski A, Jeste DV (1986) Neurological aspects of tardive dyskinesia. In: Nasrallah HA, Weinberger DR (eds) The neurology of schizophrenia. Elsevier Science Publishers, Amsterdam, pp 97–119

    Google Scholar 

  • Lucey JL, Dinan TG (1992) Orofacial dyskinesia and the alcohol dependence syndrome. Psychol Med 22:79–83

    Google Scholar 

  • Mahadik SP, Laev H, Korenovsky A, Karpiak SE (1988) Haloperidol alters rat CNS cholingergic system: enzymatic and morphological analyses. Biol Psychiatry 24:199–217

    Google Scholar 

  • Morgenstern H, Glazer WM (1993) Identifying risk factors for tardive dyskinesia amoong long-term outpatients maintained with neuroleptic medications: results of the Yale Tardive Dyskinesia Study. Arch Gen Psychiatry 50:723–733

    Google Scholar 

  • Mukerjee S, Reddy R, Schnur DB (1991) A developmental model of negative syndromes in schizophrenia. In: Greden JF, Tandon R (eds) Negative schizophrenic symptoms: pathophysiology and clinical implications. American Psychiatric Press, Washington, DC, pp 173–186

    Google Scholar 

  • National Institute of Mental Health (1975) Abnormal involuntary movement scale (AIMS). Early Clinical Drug Evaluation Unit Intercom 4:3–6

    Google Scholar 

  • Olivera AA, Kiefer MW, Manley NK (1990) Tardive dyskinesia in psychiatric patients with substance use disorders. Am J Drug Alcohol Abuse 16 [1&2]:57–66

    Google Scholar 

  • Oscar-Berman M (1987) Neurophychological consequences of alcohol abuse: questions, hypotheses and models. In: Parsons OA, Butters N, Nathan PE (eds) Neuropyschology of alcoholism: implications for diagnosis and treatment. The guilford Press, New York, pp 256–269

    Google Scholar 

  • Overall JE, Gorham DR (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10:799–812

    Google Scholar 

  • Overall JE, Gorham DR (1988) The Brief Psychiatric Rating Scale (BPRS): recent developmenta in ascertainment and scalling. Psychopharmacol Bull 24:97–99

    Google Scholar 

  • Paulsen JS, Heaton RK, Jeste DV (1994) Neuropsychological impairment in tardive dyskinesia. Neuropsychology 8 [2]:227–241

    Google Scholar 

  • Porjesz B, Begleiter H (1987) Evoked brain potentials and alcoholism. In: Parsons OA, Butters N, Nathan PE (eds) Neuropsychology of alcoholism: implications for diagonsis and treatment. The Guilford Press, New York, pp 45–63

    Google Scholar 

  • Risberg J, Berglund M (1987) Cerebral blood flow and metabolism in alcoholics. In: Parsons OA, Butters N, Nathan PE (eds) Neuropsychology of alcoholism: implications for diagnosis and treatment. The Guilford Press, New York, pp 64–75

    Google Scholar 

  • Ryan C, Butters N (1980) Alcoholism and Premature aging: a neuropsychological perspective. Alcohol Clin Exp Res 6:79–96

    Google Scholar 

  • Saltz BL, Woemer MG, Kane JM, Lieberman JA, Alvir JM, Bergmann KJ, Blank K, Koblenzer J, Kahaner K (1991) Prospective study of tardive dyskinesia incidence in the elderly. JAMA 266:2402–2406

    Google Scholar 

  • Sandyk R (1990) Pineal calcification and subtypes of tardive dyskinesia. Int J Neurosci 53:223–229

    Google Scholar 

  • Sandyk R, Kay SR (1991) The relationship of tardive dyskinesia to positive schizophreniua. Int J Neurosci 56:107–139

    Google Scholar 

  • Sandyk R, Pardeshi R (1990) Mood-depressant fluctuations in the severity of tardive dyskinesia and psoriasis vulgaris in a patient with schizoaffective disorder: possible role of metatonin. Int J Neurosci 50:215–221

    Google Scholar 

  • Schneider JS (1989) Levodopa induced dyskinesia in parkinsonian monkeys: relationship to extent of nigrostriatal damage. Pharmacol Biochem Behav 34:193–196

    Google Scholar 

  • Schooler N, Kane JM, (1982) Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 39:486–487

    Google Scholar 

  • Sewell DD, Yoshinobu BH, Caligiuri MP, Jeste DV (1992) Metoclopramide-associated tardive dyskinesia in hemodialysis patients with diabetes mellitus: two case reports. Gen Hosp Psychiatry 14:416–419

    Google Scholar 

  • Shaw TG (1987) Alcohol and brain function: an appraisal of cerebral blood flow data: Parsons OA, Butters N, Nathan PE (eds) Neuropsychology of alcoholism: implications for diagnosis and treatment. The Guilford Press, New York, pp 129–152

    Google Scholar 

  • Simpson GM, Angus JW (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 45 [s212]:11–12

    Google Scholar 

  • Simpson GM, Lee JH, Zoubok B, Gardos G (1979) A rating scale for tardive dyskinesia. Psychophamacology 64:171–179

    Google Scholar 

  • Tarsy D, Granacher R, Bralower M (1977) Tardive dyskinesia in young adults. Am J Psychiatry 134:1032–1034

    Google Scholar 

  • Waddington JL, Youssef HA (1986) An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms. Am J Psychiatry 143:1162–1165

    Google Scholar 

  • Wilkson DA (1987) CT scan and neuropsychological assess ments of alcoholism. In: Parsons OA, Butters N, Nathan PE (eds) Neuropsychology of alcoholism: implications for diagnosis and treatment. The Guilford Press, New York, pp 76–102

    Google Scholar 

  • Williams HL (1987) Evoked brain potentials and alcoholism: questions, hypotheses, new approaches. In: Parsons OA, Butters N, Nathan PE (eds) Neuropsychology of alcoholism: implications for diagnosis and treatment. The Guilford Press, New York, pp 103–128

    Google Scholar 

  • Woerner MG, Saltz BL, Kane JM, Lieberman JA, Alvir MJ (1993) Diabetes and development of tardive dyskinesia. Am J Psychiatry 150:966–968

    Google Scholar 

  • Wolf ME, DeWolfe AS, Ryan JJ, Lips O, Mosnaim AD (1985) Vulnerability to tardive dyskinesia. J Clin Psychiatry 46:367–368

    Google Scholar 

  • Yassa R, Jeste DV (1992) Gender differences in tardive dyski nesia: a critical review of the literature. Schizophr Bull 18 [4]:701–715

    Google Scholar 

  • Yassa R, Lal S, Korpassy A, Ally J (1987) Nicotine exposure and tardive dyskinesia. Biol Psychiatry 22:67–72

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of California at San Diego, 3350 La Jolla Village Drive, 9-116-B, 92161, San Diego, CA, USA

    J. S. Paulsen, M. P. Caligiuri, B. Palmer, L. A. McAdams & D. V. Jeste

Authors
  1. J. S. Paulsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. P. Caligiuri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Palmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. A. McAdams
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. V. Jeste
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paulsen, J.S., Caligiuri, M.P., Palmer, B. et al. Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients: a prospective longitudinal study. Psychopharmacology 123, 307–314 (1996). https://doi.org/10.1007/BF02246639

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02246639

Key words

Search

Navigation